BR9507872A - Método e composição para aumentar a absorção de cálcio - Google Patents

Método e composição para aumentar a absorção de cálcio

Info

Publication number
BR9507872A
BR9507872A BR9507872A BR9507872A BR9507872A BR 9507872 A BR9507872 A BR 9507872A BR 9507872 A BR9507872 A BR 9507872A BR 9507872 A BR9507872 A BR 9507872A BR 9507872 A BR9507872 A BR 9507872A
Authority
BR
Brazil
Prior art keywords
composition
calcium absorption
increasing calcium
increasing
absorption
Prior art date
Application number
BR9507872A
Other languages
English (en)
Inventor
Prasad S Adusumilli
Vimala Sivapragasam
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR9507872A publication Critical patent/BR9507872A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9507872A 1994-05-13 1995-05-12 Método e composição para aumentar a absorção de cálcio BR9507872A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24275394A 1994-05-13 1994-05-13
US33553794A 1994-11-07 1994-11-07
PCT/US1995/006239 WO1995031186A1 (en) 1994-05-13 1995-05-12 Method and composition for increasing calcium uptake

Publications (1)

Publication Number Publication Date
BR9507872A true BR9507872A (pt) 1997-09-23

Family

ID=26935311

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507872A BR9507872A (pt) 1994-05-13 1995-05-12 Método e composição para aumentar a absorção de cálcio

Country Status (10)

Country Link
US (1) US5919491A (pt)
EP (1) EP0759745A4 (pt)
JP (1) JPH10500412A (pt)
CN (1) CN1108150C (pt)
AU (1) AU707454B2 (pt)
BR (1) BR9507872A (pt)
CA (1) CA2190188A1 (pt)
NZ (1) NZ287277A (pt)
TW (1) TW446562B (pt)
WO (1) WO1995031186A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US5972389A (en) * 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
DE19920833A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit quellbaren Polymeren
US6488962B1 (en) * 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6887897B2 (en) 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US8778395B2 (en) 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20080317807A1 (en) * 2007-06-22 2008-12-25 The University Of Hong Kong Strontium fortified calcium nano-and microparticle compositions and methods of making and using thereof
US20120244218A1 (en) * 2011-03-25 2012-09-27 Durkee Shane E Calcium supplement
WO2013114390A1 (en) * 2012-01-02 2013-08-08 Medreich Limited Gastro retentive drug delivery system of calcium supplements
US20140363504A1 (en) * 2013-06-11 2014-12-11 The Beauty Nation Ptd Ltd Absorbable encapsulated calcium in hypromellose capsule

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
JPS57189671A (en) * 1981-05-19 1982-11-22 Matsutani Kagaku Kogyo Kk Water dispersible bone powder and its preparation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
EP0208362A1 (en) * 1985-06-28 1987-01-14 The Procter & Gamble Company Dietary supplements containing iron and enterically coated calcium
US4814177A (en) * 1986-03-18 1989-03-21 Board Of Regents, University Of Texas System Ultradense and more soluble and bioavailable preparations of calcium citrate
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
GB2212396A (en) * 1987-12-18 1989-07-26 Procter & Gamble Dietary supplement comprising calcium and delayed release coated iron
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
ES2124303T3 (es) * 1992-03-25 1999-02-01 Depomed Inc Formas de dosificacion de farmacos orales de liberacion retardada a base de hidroxietilcelulosa.

Also Published As

Publication number Publication date
CN1152258A (zh) 1997-06-18
WO1995031186A1 (en) 1995-11-23
AU707454B2 (en) 1999-07-08
CA2190188A1 (en) 1995-11-23
EP0759745A4 (en) 1997-11-19
JPH10500412A (ja) 1998-01-13
NZ287277A (en) 1998-05-27
EP0759745A1 (en) 1997-03-05
US5919491A (en) 1999-07-06
TW446562B (en) 2001-07-21
CN1108150C (zh) 2003-05-14
AU2593995A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
BR9606575A (pt) Composição incapacitante e dispositivo para o emprego de uma composição incapacitante
FI965093A (fi) Laite ja menetelmä kellon säätämiseksi ja kytkemiseksi
DE69604922T2 (de) Anschwellendes bahnmaterial
BR9602695A (pt) Composto método e composição para tratamento de distúrbios hiperproliferativos
BR9504194A (pt) Composiçao de poliuretano
BR9508927A (pt) Processo para a preparação de compostos e composto
NO972549D0 (no) Absorberende material
BR9508190A (pt) Método para fabricar prepreg
BR9508367A (pt) Conjunto de rolo e método para fabricação do mesmo
DK0797551T3 (da) Cementagtig sammensætning
DE69504931T2 (de) Wegwerfwindel
BR9507872A (pt) Método e composição para aumentar a absorção de cálcio
PT909270E (pt) Processo para a preparacao de 2,4-dihidroxipiridina e de 2,4-dihidroxi-3-nitropiridina
DE69500131D1 (de) Positive Resistzusammensetzung
BR9407636A (pt) Método e aparelho para absorver sulfeto de hidrogenio
DE69530670D1 (de) Verfahren zur absorption von interleukine
DE19581444T1 (de) Zweiblättrige Säge
FI942298A0 (fi) Menetelmä ja sovitelma tilaelementtien siirtämiseksi
DE69532410D1 (de) Härtbare zusammensetzung
BR9509899A (pt) Composição modificadora de sabor
FI970499A (fi) Menetelmä ja aine lipidien absorption vähentämiseksi
BR9505656A (pt) Composto composição e método para a estabilização de material orgánico
BR9704832A (pt) Composição anti-formação de domo para uma máscara de sombra e processo para sua preparação
BR9704984A (pt) Macaco e método para fabricação de um macaco
BR9609527A (pt) Composição de poliol e método melhorado para preparar um poliol

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]